$VYCO Balance Sheet | Understand Stock

$VYCO

$0.07 +$0.00 (0.0%) Close

$VYCO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
ASSETS
Current Assets
Cash
Trade accounts receivable, net
Inventory
Prepaid expenses and other current assets
Current assets of discontinued operations
Total Current Assets
Fixed assets, net
Patents, net of accumulated amortization
Other assets
Non-current inventory, net
Security deposits
Operating lease - right of use assets
Total Intangible and Other assets
Total Other Assets
TOTAL ASSETS

LIABILITIES AND STOCKHOLDERS’ DEFICIENCY
Current Liabilities
Accounts payable
Accrued interest
Nonrelated Party
Related Party
Total accrued interest

Accrued interest: Related party
Accrued liabilities - Related Party
Notes payable: Other
Notes payable: Related Party
Accrued liabilities
Nonrelated Party
Related Party
Total accrued liabilities
Dividends payable - Related Party
Notes payable
Nonrelated Party
Related Party
Current operating lease liabilities
Current liabilities of discontinued operations
Total Current Liabilities

Operating lease liability - long term
Loan payable - SBA EIDL
Total Long-term Liabilities
Total Liabilities
STOCKHOLDERS’ DEFICIENCY
Preferred Stock, value
Series D Preferred Stock
Total preferred Stock, value
Common Stock, $0.0001 par value, 55,000,000 shares authorized at June 30, 2026 and December 31, 2025; 33,476,130 shares issued and 33,372,796 shares outstanding at June 30, 2026 and December 31, 2025, respectively
Additional Paid-in Capital
Treasury Stock (103,334 shares of Common Stock as at December 31, 2024 and December 31, 2023 respectively, at cost)
Treasury Stock (103,334 shares of Common Stock as at June 30, 2026 and December 31, 2025 respectively, at cost)
Accumulated Deficit
Accumulated Other Comprehensive Income
Total Stockholders’ Deficiency
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIENCY

Comments